Skip to main content

Stock For 7 days

W H BRADY & CO (501391) (155)

W. H. Brady & Company Limited designs, manufactures, and markets material
handling equipment primarily in India. Its products include chain pulley blocks,
travelling trolleys, electric wire rope hoists, electric chain hoists, hand pallet
trucks, manual chain hoists and trolleys, hydraulic pallet trucks, electric winches,
and cranes. The company is also involved in trading mechanical lifting
equipment, high precision textile machinery and auxiliaries, metals, and
specialized transportation equipment. In addition, it offers marketing and sales
promotion services, logistics management, installation, testing, and
commissioning, and after sales services; and provides liasoning with government
and quasi-government agencies, manages customer databases, gathers market
intelligence, supports engineering and supporting software services, manages
and executes projects, and offers tax advisory services, as well as operates,
maintains, and manages electro-mechanical services at the airport. Further, the
company provides property facilities management services, including building
management and maintenance services, people services, and business services.
The company serves various industries, such as steel, chemicals, cement,
power, textiles, metals, minerals, etc. It sells its products through dealers and
distributors. The company was founded in 1895 and is based in Mumbai, India.
It has an equity base of just Rs.2.55 crore that is supported by reserves of
around Rs.12.59 crore. It has a share book value of Rs.70.88.
The Promoters hold 73.76% while the investing public holds 26.09% stake in the
company.
For Q1FY16, sales have remains flat to Rs.5.02crore. Despite of flat topline &
rise in income tax, PAT has jumped by 24.56% to Rs.0.71crore. Q1FY16 EPS
stood at Rs.2.77. The scrip is trading at P/E multiple of 14.5. It has paid 10%
dividend for FY15.Investors can buy this stock with a stop loss of 180 With 7 days Target 300

Comments

Popular posts from this blog

Best Buy For Monday Upper Circuit Expected TCI FINANCE

*Intraday & Short Term News For Monday* *Fii And Dii News*   *TCI FINANCE LTD (501242 & NSE) (31)*   Incorporated in 1973, TCI Finance Ltd (TCIFL) is a Non-Banking Finance Company (NBFC) registered with the RBI and engaged in the business of Inter-Corporate Deposits, investment in equities of bodies corporate etc.   The Company was promoted by Mr. Mahendra Agarwal, who is also the Managing Director and CEO of Gati Ltd, a pioneer in express distribution and supply chain and promoted by TCFIL   The Rs.2 paid-up share of Gati Ltd currently trades at Rs.113. TCIFL has one subsidiary - ITAG Business Solutions Ltd engaged in the business of Knowledge Process Outsourcing (KPO) in the domain of Intellectual Property Services.   *It is co-promoter of GATI LTD. Company is holding 55,12,455 shares (5.09%) stake in GATI LTD. At CMP value of investments is around Rs.62.3crore. Equity is Rs.12.87crore. Thus value of investment works out to Rs.48.4 per share ...

Danlaw Technologies India Ltd: For multi-bagger gains (BSE Code: 532329) (CMP: Rs. 60.75) (FV: Rs.10)

The earnings season so far has been weak and worries over domestic growth continue to weigh on the market sentiment which has led the markets back on the downward path.. A value investor, however, need not worry about the broad markets as value stocks perform better and post good results. One such value-pick is Danlaw Technologies India Ltd. (DTIL). Company background: DTIL is the offshore technology and product development center of its parent company - Danlaw Incorporated, founded by Mr. Raju Dandu and Mr. Lloyd Lawrence in Michigan, USA in 1984. DTIL’s mission is to provide high quality services and products in Automotive Electronics, develop R&D driven Signal Processing technologies for communication and control, configure solutions and provide exceptional Information Technology (IT) services in the areas of education, health, banking and e-governance and provide world-class products and solutions for secured access through biometric access control technologies with intellige...

Some Opportunities Are left in Pharma Sector

Torrent Pharmaceuticals  reported impressive 75% growth in revenues and profit in the first quarter of FY 2016. The sterling performance was driven by the launch of new product in the US market, which has limited competition at present. The focus is on the therapeutic segments of cardiovascular and CNS. There is presence in gastro-intestinal, diabetology, anti-infective, pain management, nephrology, oncology, gynecology and pediatric segments as well. The manufacturing plants for formulations and bulk drugs have been approved by authorities of several regulated and semi-regulated markets such as the US, the UK, Brazil, Germany, Australia and South Africa. Capacity will increase almost 100% once the new plant at Dahej in Gujarat becomes operational. The plant will be one of the largest pharmaceuticals manufacturing facilities in the country at a single location. The unit will primarily cater to the key regulated markets of the US and Europe. Approval from regulators such...